The Warrior Reports on Dismal Doyle’s Victory

Written by Brandon on November 8, 2006 – 12:01 pm -

Welcome, if you're new here, you may want to subscribe to our RSS feed or subscribe to our email newsletter. Thanks for visiting!

Daniel Suhr does a great job of analyzing Doyle’s victory in today’s edition of The Warrior:Marquette University’s Independent News Source (www.thewarrior.org).

Alternative Theory
The overall prediction is that Doyle will continue to govern from the mushy middle. On values questions he will wield his veto pen to stop Republicans from passing concealed carry, abortion restrictions etc. On social questions, he will continue his current track of spending more on education and using targeted tax credits and deductions to help working-class families.

Wisconsinites will see taxes continue to inch up incrementally under a quasi-freeze, but Doyle won’t be able to stray too far because his starting point will always be the Republican Legislature’s budget.

Yet Doyle suggested on WISC-TV this campaign is “quite possibly my last.” (Republicans have capitalized on these rumors to motivate their base, suggesting that Doyle has only been moderate during his first term because he wanted so badly to be re-elected. Once the need to appeal to independents and moderates is removed because he’s not running again, Doyle will govern from his hard-left heart, as the theory goes. Only time will tell if that theory is proven true; regardless, Doyle will still be limited to governing from the common ground he can find with Legislative Republicans.

Conclusion
No one will accuse Doyle of being the heir to John F. Kennedy. He’s bald and bland on the stump. But maybe that’s why the undecided voters went with him – he’s safe. He makes the trains run on time. He’s not flashy, but he not threatening either. And he’s a technocrat, not a politician. So even though only 32 percent of voters think Wisconsin is headed in the right direction, the incumbent governor wins. In a quintessentially purple state, Doyle navigated the last four years just right. He used his veto pen to keep his liberal base happy, and he used his bully pulpit to push small ideas that appeal to moderates. Toss in $12 million of television advertising, and in a heavily Democrat cycle you clinch four more years. What he’ll make of them will be as much up to the Republican legislative majority as Doyle himself.

Last 5 posts by Brandon

Posted in Brave New World, Dismal Doyle, Ministry of Strategery, US News and Liberal Debacles |

5 Comments to “The Warrior Reports on Dismal Doyle’s Victory”

  1. deke Says:

    The Governor will not need to veto crazy items from the Assembly since they will never pass the Democratic State Senate. It is a new day in Madison!

  2. Luke Says:

    Crazy things like voter ID?

  3. George Gallup Says:

    Crazy things like restrictions on embryonic stem cell research. Not only will such legislation not pass through the Democrat-controlled Senate, it won’t even pass the Republican-controlled Assembly. There are more than enough moderate Republicans among the 52-seat majority to vote with the Democrats to restrict such research.

    This means that the fight over embryonic stem cell research in Wisconsin is done forever. How can such a bold prediction be made? Because with a couple year start, the research will begin producing treatments and cures. The horse will be out of the barn.

    Some of you may have missed the news out of Madison in September that stem cell scientist Jamie Thomson has started a second company. This one will utilize technology which he has already perfected to produce blood products like platelets, under contract with the US military. When fully operational, the company’s products will have use on the battlefield to treat the severely wounded. Again, this isn’t some pie-in-the-sky idea; the technology is ready to roll.

    This will further marginalize the opponents of embryonic stem cell research. Polling done on likely voters in Wisconsin in 2005 by a national Republican pollster revealed that nearly 70% of likely voters support embryonic stem cell research.

  4. SPET3R Says:

    I’m sure they do until they realize what it actually is. Not many are educated in the difference between Adult and Embryonic. I’d like to see what the question in that survey said… If it said “Do you support Stem Cell Research”? I would agree with you. However, if it didn’t mention embrionic, that would be a pretty slanted poll and not worth citing… As far as that Jamie Thompson… how is that being funded…? Sounds like by government since its military. Give me a list of venture capitalists… give me a list of accomplishments. Partnership with the military? The only way this research can continue is through FEDERAL FUNDING.

    Remember, Bill Clinton didn’t even support Embrionic Stem Cells. George Bush brought this to the forefront. Adult stem cell research is producing results… embrionic is not. Pouring billions into it is a huge waste when there is more pressing issues.

  5. George Gallup Says:

    The poll was done on EMBRYONIC stem cell research, and it was done by John Gard’s Washington pollster. Nearly 70% of Wisconsin residents support such research. Your position is the distinct minority position.

    With the change in control of the Senate, the Governor won’t even have to veto any wingut stem cell legislation because it will never get to his desk. No such bill will even pass the Assembly, because there are enough stem cell supporters among the 52 Republicans to vote against it.

    Here is the press release concerning Jamie Thomson’s new company:

    For Immediate Release
    Tuesday, October 10, 2006
    Carla Vigue, Office of the Governor, 608-261-2162
    Tony Hozeny, Department of Commerce, 608-267-9661

    Governor Doyle Announces $1 Million for Stem Cell Start-up Company
    State has $750 Million Strategy to be America’s Stem Cell Leader

    As part of his directive to provide $5 million in state funding to companies involved with stem cell research, Governor Jim Doyle today announced funding for Stem Cell Products, Inc. The funding will support the company’s commercial research and development of processes to make safe, effective blood products from embryonic stem cells. The company was founded, in part, by UW-Madison biology Professor James Thomson who isolated the first human embryonic stem cell in 1998 - making Wisconsin the birthplace of stem cell research.

    “This company is an example of the enormous potential of embryonic stem cell research not only to heal illness but to create new, high paying jobs in Wisconsin,” Governor Doyle said. “As Governor, I’ll continue fighting to make sure that top researchers and embryonic stem cell companies are welcomed with open arms and have the strong support of the state. Their work will save lives, transform our economy and open the doors to the jobs of the future.”

    Stem Cell Products, Inc. (SCP), founded by UW researchers James Thomson, Igor Slukvin and Dong Chen with others, will receive $750,000 in loans and a $250,000 grant from the Wisconsin Department of Commerce. The company has also been designated as a Qualified New Business Venture for investor tax credits under the Angel Investor and Venture Fund Tax Credit Programs.

    The company will initially concentrate on process improvements in the manufacture and delivery of embryonic stem cell derived red blood cells and platelets. The company intends to develop techniques to permit industrial-scale manufacturing of embryonic stem cell derived blood products for human clinical use.

    Platelets are in short supply and are needed by the U.S. military for transfusions into soldiers wounded in battle. The military is interested in the technology that Stem Cell Products is developing that would make platelets available to combat theater area hospitals. Currently, the military flies wounded soldiers from Iraq to hospitals in Germany so they can have access to platelets.

    “Blood platelets are a critical, lifesaving medical resource, but they are in short supply. Using advances from embryonic stem cell research, this company could revolutionize the process and help save lives,” Doyle added. “U.S. soldiers serving in combat could be among the first to benefit. The U.S. military has a significant need for platelets for soldiers who have been wounded. The technology being developed by this company could make platelets more available at military hospitals in combat zones.”

    “We are pleased and honored to be the recipient of this grant and loan, and we thank the State of Wisconsin and Governor Doyle for the confidence placed in stem cell technology and SCP,” said Nick Seay, Senior Vice President for SCP. “The scientist founders of our company have demonstrated that important components of the blood system can be produced from human embryonic stem cells in culture. Now our company is working hard is to scale up these processes to supply blood products for human health.”

    Governor Doyle also met with Dan and Chris Rotert and their 13-year old son Zack, who was diagnosed with diabetes one year ago. Zack tests his blood sugar 8 times a day and takes about 6 shots of insulin a day. Zack will be insulin dependent until a cure for diabetes is found.

    The Governor also vowed to continue to veto any legislation that makes its way to his desk that would be harmful to embryonic stem cell research in Wisconsin. In 2005, Governor Doyle vetoed attempts by the Wisconsin State Legislature to criminalize the most promising techniques used in this research.

    Over the last three years, Governor Doyle has vastly expanded the state’s investment in this critical field and set a goal that the state should capture 10% of the stem cell market by 2015. He also launched a $750 million initiative to develop stem cell research and biotechnology in Wisconsin. The centerpiece of this effort is the planned construction of the Institutes for Discovery in Madison.

    In September, Governor Doyle announced a historic stem cell research partnership agreement that will pave the way for thousands of stem cell research jobs in Wisconsin. The Governor also announced new state financial incentives to help lure companies to our state, and help achieve his goal of capturing 10 percent of the stem cell market by 2015.

    Specifically, the Doyle administration has reached an agreement with the Wisconsin Alumni Research Foundation (WARF), which holds patents and royalty rights on some of the most promising stem cell lines in the world. Under this agreement, all companies conducting research at non-profit and academic institutions located in Wisconsin will receive a free non-exclusive research license under the stem cell patents held by WARF for that sponsored research. In other words, they will not have to pay royalty fees to WARF for that research that would be required if the research was conducted in another state. The agreement will give the state a significant competitive advantage over California and other states.

    Experts predict that the market for stem cell products could reach $10 billion over the next ten years, translating into more than 100,000 jobs. In April, Governor Doyle set out to capture 10 percent of that market to ensure Wisconsin keeps its status as the leader and pioneer in stem cell research and development, and add tens of thousands high-end biotechnology jobs.

    Currently, Wisconsin has a biotechnology workforce of 30,000 that generates nearly $8 billion for the economy.

Leave a Comment